Impact of therapy with statins, beta-blockers and angiotensin-converting enzyme inhibitors on plasma myeloperoxidase in patients with coronary artery disease

Clinical Research in Cardiology

Volumn 100, Issue 4, 2011, Pages 327-333

  Ndrepepa, Gjin ^a   Braun, Siegmund ^a   Schömig, Albert ^a,b   Kastrati, Adnan ^a  

^a TECHNICAL UNIVERSITY OF MUNICH   (Germany)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Angiotensin converting enzyme inhibitors; Beta blockers; Coronary artery disease; Myeloperoxidase; Statins

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; HEPARIN; MYELOPEROXIDASE; STATIN;

ACUTE CORONARY SYNDROME; ANGIOGRAPHY; ARTICLE; BLOOD SAMPLING; CARDIOVASCULAR RISK; CONTROLLED STUDY; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; DRUG EFFECT; ENZYME BLOOD LEVEL; HUMAN; HUMAN CELL; HUMAN TISSUE; MAJOR CLINICAL STUDY; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION; UNSTABLE ANGINA PECTORIS;

ACUTE DISEASE; ADRENERGIC BETA-ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CORONARY ANGIOGRAPHY; CORONARY ARTERY DISEASE; FEMALE; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; PEROXIDASE;

EID: 79954443933     PISSN: 18610684     EISSN: 18610692     Source Type: Journal    
DOI: 10.1007/s00392-010-0247-2     Document Type: Article

References (28)

1. Andreou I, Tousoulis D, Miliou A, Tentolouris C, Zisimos K, Gounari P, Siasos G, Papageorgiou N, Papadimitriou CA, Dimopoulos MA, Stefanadis C (2010) Effects of rosuvastatin on myeloperoxidase levels in patients with chronic heart failure: a randomized placebo-controlled study. Atherosclerosis 210:194-198
2. FS Apple LA Pearce A Chung R Ler MM Murakami 2007 Multiple biomarker use for detection of adverse events in patients presenting with symptoms suggestive of acute coronary syndrome Clin Chem 2007 874 881 10.1373/clinchem.2006.080192 (Pubitemid 46744243)
3. H Beril Gok I Solaroglu O Okutan B Cimen E Kaptanoglu S Palaoglu 2007 Metoprolol treatment decreases tissue myeloperoxidase activity after spinal cord injury in rats J Clin Neurosci 14 138 142 17161287 10.1016/j.jocn.2005.10.016 1:CAS:528:DC%2BD28Xht12rtrzO (Pubitemid 44855611)
4. ML Brennan MS Penn F Van Lente V Nambi MH Shishehbor RJ Aviles M Goormastic ML Pepoy ES McErlean EJ Topol SE Nissen SL Hazen 2003 Prognostic value of myeloperoxidase in patients with chest pain N Engl J Med 349 1595 1604 14573731 10.1056/NEJMoa035003 1:CAS:528:DC%2BD3sXosFWktbo%3D (Pubitemid 37288567)
5. A Buffon LM Biasucci G Liuzzo G D'Onofrio F Crea A Maseri 2002 Widespread coronary inflammation in unstable angina N Engl J Med 347 5 12 12097534 10.1056/NEJMoa012295 (Pubitemid 34728951)
6. PA Cowled A Khanna PE Laws JB Field A Varelias RA Fitridge 2007 Statins inhibit neutrophil infiltration in skeletal muscle reperfusion injury J Surg Res 141 267 276 17559881 10.1016/j.jss.2006.11.021 1:CAS:528:DC%2BD2sXnslWrsrc%3D (Pubitemid 47042054)
7. FM de Gusmão C Becker MH Carvalho LF Barros 2005 Angiotensin II inhibition during myocardial ischemia-reperfusion in dogs: effects on leukocyte infiltration, nitric oxide synthase isoenzymes activity and left ventricular ejection fraction Int J Cardiol 100 363 370 15837077 10.1016/j.ijcard.2004.03. 017
8. KM Eggers M Dellborg N Johnston J Oldgren E Swahn P Venge B Lindahl 2010 Myeloperoxidase is not useful for the early assessment of patients with chest pain Clin Biochem 43 240 245 19822136 10.1016/j.clinbiochem.2009.09.026 1:CAS:528:DC%2BC3cXpslSkug%3D%3D
9. Fox KM, for the European Trial on Reduction of Cardiac Events with Perindopril in Stable Coronary Artery Disease Investigators (2003) Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomised, double-blind, placebo-controlled, multicentre trial (the EUROPA study). Lancet 362:782-788 (Pubitemid 37093919)
10. F Gao J Chen BL Lopez TA Christopher J Gu P Lysko RR Ruffolo Jr EH Ohlstein XL Ma TL Yue 2000 Comparison of bisoprolol and carvedilol cardioprotection in a rabbit ischemia and reperfusion model Eur J Pharmacol 406 109 116 11011041 10.1016/S0014-2999(00)00641-5 1:CAS:528:DC%2BD3cXmslOitLk%3D
11. M Graninger R Reiter C Drucker E Minar B Jilma 2004 Angiotensin receptor blockade decreases markers of vascular inflammation J Cardiovasc Pharmacol 44 335 339 15475831 10.1097/01.fjc.0000137160.76616.cc 1:CAS:528: DC%2BD2cXntV2hs7o%3D (Pubitemid 39129452)
12. J Hippisley-Cox C Coupland 2006 Effect of statins on the mortality of patients with ischaemic heart disease: population based cohort study with nested case-control analysis Heart 92 752 758 16216864 10.1136/hrt.2005.061523 1:CAS:528:DC%2BD28XlvVSksbY%3D (Pubitemid 43799205)
13. AP Kumar WF Reynolds 2005 Statins downregulate myeloperoxidase gene expression in macrophages Biochem Biophys Res Commun 331 442 451 15850779 10.1016/j.bbrc.2005.03.204 1:CAS:528:DC%2BD2MXjsFGrtL8%3D (Pubitemid 40602657)
14. T Macickova J Pecivova R Nosal A Lojek M Pekarova D Cupanikova 2008 Inhibition of superoxide generation and myeloperoxidase release by carvedilol after receptor and nonreceptor stimulation of human neutrophils Neuro Endocrinol Lett 29 790 793 18987595 1:CAS:528:DC%2BD1MXht1Wnsrs%3D
15. MC Meuwese MD Trip S van Wissen JN van Miert JJ Kastelein ES Stroes 2008 Myeloperoxidase levels are not associated with carotid atherosclerosis progression in patients with familial hypercholesterolemia Atherosclerosis 197 916 921 17875305 10.1016/j.atherosclerosis.2007.08.011 1:CAS:528: DC%2BD1cXktFCktb4%3D (Pubitemid 351417895)
16. TJ Mocatta AP Pilbrow VA Cameron R Senthilmohan CM Frampton AM Richards CC Winterbourn 2007 Plasma concentrations of myeloperoxidase predict mortality after myocardial infarction J Am Coll Cardiol 49 1993 2000 17512353 10.1016/j.jacc.2007.02.040 1:CAS:528:DC%2BD2sXlsF2hur4%3D (Pubitemid 46734639)
17. DA Morrow CP Cannon RL Jesse LK Newby J Ravkilde AB Storrow AH Wu RH Christenson FS Apple G Francis W Tang National Academy of Clinical Biochemistry 2007 National academy of clinical biochemistry laboratory medicine practice guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes Clin Chem 53 552 574 17384001 10.1373/clinchem.2006. 084194 1:CAS:528:DC%2BD2sXksFWht7c%3D (Pubitemid 46580223)
18. G Ndrepepa S Braun J Mehilli N von Beckerath A Schömig A Kastrati 2008 Myeloperoxidase level in patients with stable coronary artery disease and acute coronary syndromes Eur J Clin Invest 38 90 96 18226042 10.1111/j.1365-2362.2007.01908.x 1:CAS:528:DC%2BD1cXjsVeqsLw%3D (Pubitemid 351143413)
19. SJ Nicholls SL Hazen 2005 Myeloperoxidase and cardiovascular disease Arterioscler Thromb Vasc Biol 25 1102 1111 15790935 10.1161/01.ATV.0000163262. 83456.6d 1:CAS:528:DC%2BD2MXksVWqsLk%3D (Pubitemid 40776595)
20. T Ohtsuka M Hamada G Hiasa O Sasaki M Suzuki Y Hara Y Shigematsu K Hiwada 2001 Effect of beta-blockers on circulating levels of inflammatory and anti-inflammatory cytokines in patients with dilated cardiomyopathy J Am Coll Cardiol 37 412 417 11216955 10.1016/S0735-1097(00)01121-9 1:CAS:528: DC%2BD3MXhsl2jtL0%3D
21. A Stefanescu S Braun G Ndrepepa T Koppara H Pavaci J Mehilli A Schömig A Kastrati 2008 Prognostic value of plasma myeloperoxidase concentration in patients with stable coronary artery disease Am Heart J 155 356 360 18215608 10.1016/j.ahj.2007.10.017 1:CAS:528:DC%2BD1cXosV2htg%3D%3D
22. P Stenvinkel E Rodríguez-Ayala ZA Massy AR Qureshi P Barany B Fellström O Heimburger B Lindholm A Alvestrand 2006 Statin treatment and diabetes affect myeloperoxidase activity in maintenance hemodialysis patients Clin J Am Soc Nephrol 1 281 287 17699218 10.2215/CJN.01281005 1:CAS:528:DC%2BD28Xjs1Grtb8%3D
23. G Weitz-Schmidt 2002 Statins as anti-inflammatory agents Trends Pharmacol Sci 23 482 487 12368073 10.1016/S0165-6147(02)02077-1 1:CAS:528: DC%2BD38Xntl2rtbY%3D (Pubitemid 35279610)
24. World Health Organization (1999) Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO Consultation. Part 1 diagnosis and classification of diabetes mellitus. World Health Organization, Geneva
25. S Yusuf J Wittes L Friedman 1988 Overview of results of randomized clinical trials in heart disease. I. Treatments following myocardial infarction JAMA 260 2088 2093 2901501 10.1001/jama.260.14.2088 1:STN:280: DyaL1czjtlejtg%3D%3D
26. U Zeymer KG Parhofer D Pittrow C Binz M Schwertfeger T Limbourg J Röther 2009 Risk factor profile, management and prognosis of patients with peripheral arterial disease with or without coronary artery disease: results of the prospective German REACH registry cohort Clin Res Cardiol 98 249 256 19221687 10.1007/s00392-009-0754-1
27. Y Zheng W Ma Y Zeng J Liu S Ye S Chen L Lan R Erbel Q Liu 2010 Comparative study of clinical characteristics between Chinese Han and German Caucasian patients with coronary heart disease Clin Res Cardiol 99 45 50 19763659 10.1007/s00392-009-0076-3
28. T Zhou SH Zhou SS Qi XQ Shen GF Zeng HN Zhou 2006 The effect of atorvastatin on serum myeloperoxidase and CRP levels in patients with acute coronary syndrome Clin Chim Acta 368 168 172 16480969 10.1016/j.cca.2005.12.040 1:CAS:528:DC%2BD28Xlt1Cmurc%3D (Pubitemid 43776034)